Armistice Capital, LLC Painreform Ltd. Transaction History

Armistice Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.33 - $4.7 $1.96 Million - $3.94 Million	-839,346 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.06 - $6.82 $3.41 Million - $5.72 Million	839,346 New	839,346 $3.71 Million
Q4 2020 Feb 16, 2021	SELL	$4.16 - $5.4 $2.66 Million - $3.45 Million	-638,961 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.6 - $6.74 $2.94 Million - $4.31 Million	638,961 New	638,961 $2.94 Million

Ticker PRFX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 10,634,200
Market Cap $129M
Description
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-oper...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.